Electrocardiographic abnormalities in patients with sickle cell disease: A systematic review and meta‐analysis
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.30916 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Erfan Taherifard und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Electrocardiography. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
Background
Previous studies have documented that electrocardiography (ECG) can reveal a range of abnormalities, offering valuable insights into the cardiac evaluation of patients with sickle cell disease (SCD). The objective of this study is to assess the patterns of ECG abnormalities observed in these patients with SCD, and to determine their prevalence.
Method
We systematically reviewed the literature using online databases of PubMed, Scopus, Web of Science, Embase, and Google Scholar to identify original studies that reported findings of standard ECG assessments in patients with SCD. Statistical analyses were performed using the random effects model. Additional analyses including sensitivity analysis and subgroup analysis were also conducted.
Results
Analysis of data from 59 studies involving 897,920 individuals with SCD revealed that 75% of these patients had abnormal ECG findings (67%–81%), which were predominantly nonspecific ST–T changes, left ventricular hypertrophy, T‐wave changes, prolonged corrected QT (QTc) interval, and ischemic changes. Besides, it was shown that these patients had significantly higher odds of having any ECG abnormalities (OR of 17.50, 4.68–65.49), right atrial enlargement (6.09, 1.48–25.09), left ventricular hypertrophy (3.45, 1.73–6.89), right ventricular hypertrophy (7.18, 2.28–22.57), biventricular hypertrophy (10.11, 1.99–51.38), prolonged QTc interval (5.54, 2.44–12.59), ST depression (3.34, 1.87–5.97), and T‐wave changes (5.41, 1.43–20.56). Moreover, the mean of QTc interval was significantly higher among those with SCD (23.51 milliseconds, 16.08–30.94).
Conclusion
Our meta‐analysis showed a higher prevalence of abnormal ECG findings among individuals with SCD. A significant proportion of these patients had various ECG abnormalities, suggesting a potential need for regular ECG assessments for patients with SCD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
- Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Cardiovascular Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
- Student Research Committee, Jahrom University of Medical Sciences, Jahrom, Iran.
ORCID-Profile: Erfan Taherifard, Hamed Movahed, Ehsan Taherifard, Alireza Sadeghi, Niloofar Dehdari Ebrahimi, Alireza Ahmadkhani, Fatemeh Kheshti, Hossein Movahed
Zitieren
APA
Taherifard, E., Movahed, H., Taherifard, E., Sadeghi, A., Dehdari Ebrahimi, N., Ahmadkhani, A., Kheshti, F., & Movahed, H. (2024). Electrocardiographic abnormalities in patients with sickle cell disease: A systematic review and meta‐analysis. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30916
Vancouver
Taherifard E, Movahed H, Taherifard E, Sadeghi A, Dehdari Ebrahimi N, Ahmadkhani A, et al. Electrocardiographic abnormalities in patients with sickle cell disease: A systematic review and meta‐analysis. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.30916
BibTeX
@article{Taherifard2024,
author = {Taherifard, Erfan and Movahed, Hamed and Taherifard, Ehsan and Sadeghi, Alireza and Dehdari Ebrahimi, Niloofar and Ahmadkhani, Alireza and Kheshti, Fatemeh and Movahed, Hossein},
title = {Electrocardiographic abnormalities in patients with sickle cell disease: A systematic review and meta‐analysis},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.30916}
}
EUVIMED